vs
Side-by-side financial comparison of 康宝莱 (HLF) and Lifeway Foods, Inc. (LWAY), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
康宝莱 is the larger business by last-quarter revenue ($1.3B vs $55.4M, roughly 23.2× Lifeway Foods, Inc.). 康宝莱 runs the higher net margin — 6.7% vs 4.6%, a 2.1% gap on every dollar of revenue. On growth, Lifeway Foods, Inc. posted the faster year-over-year revenue change (18.0% vs 6.3%). 康宝莱 produced more free cash flow last quarter ($79.8M vs $-17.4M). Over the past eight quarters, Lifeway Foods, Inc.'s revenue compounded faster (11.4% CAGR vs 0.7%).
康宝莱是美国跨国多层次营销企业,主营膳食补充剂的研发与销售。该公司曾被指控涉嫌金字塔骗局欺诈运营,2016年与美国证监会达成协议后调整了薪酬体系,将经销商奖励与可核实的实际销售额挂钩。此外其部分产品曾被曝出引发急性肝炎的相关问题。
来福威食品公司是一家总部位于美国伊利诺伊州的健康食品企业,成立于1986年,是美国业内领先的开菲尔发酵益生菌产品供应商,这类产品主要用于调节人体微生物群平衡。
HLF vs LWAY — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | ||
|---|---|---|
| Revenue | $1.3B | $55.4M |
| Net Profit | $85.4M | $2.5M |
| Gross Margin | 77.5% | 27.8% |
| Operating Margin | 7.8% | 6.8% |
| Net Margin | 6.7% | 4.6% |
| Revenue YoY | 6.3% | 18.0% |
| Net Profit YoY | -52.0% | 1688.1% |
| EPS (diluted) | $0.81 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q4 25 | $1.3B | $55.4M | ||
| Q3 25 | $1.3B | $57.1M | ||
| Q2 25 | $1.3B | $53.9M | ||
| Q1 25 | $1.2B | $46.1M | ||
| Q4 24 | $1.2B | $46.9M | ||
| Q3 24 | $1.2B | $46.1M | ||
| Q2 24 | $1.3B | $49.2M | ||
| Q1 24 | $1.3B | $44.6M |
| Q4 25 | $85.4M | $2.5M | ||
| Q3 25 | $43.2M | $3.5M | ||
| Q2 25 | $49.3M | $4.2M | ||
| Q1 25 | $50.4M | $3.5M | ||
| Q4 24 | $177.9M | $-160.0K | ||
| Q3 24 | $47.4M | $3.0M | ||
| Q2 24 | $4.7M | $3.8M | ||
| Q1 24 | $24.3M | $2.4M |
| Q4 25 | 77.5% | 27.8% | ||
| Q3 25 | 77.7% | 28.7% | ||
| Q2 25 | 78.0% | 28.6% | ||
| Q1 25 | 78.3% | 23.9% | ||
| Q4 24 | 77.8% | 25.3% | ||
| Q3 24 | 78.3% | 25.7% | ||
| Q2 24 | 77.9% | 27.0% | ||
| Q1 24 | 77.5% | 25.8% |
| Q4 25 | 7.8% | 6.8% | ||
| Q3 25 | 9.9% | 8.8% | ||
| Q2 25 | 10.5% | 10.8% | ||
| Q1 25 | 10.1% | 3.4% | ||
| Q4 24 | 8.8% | 1.5% | ||
| Q3 24 | 10.2% | 9.1% | ||
| Q2 24 | 6.3% | 11.0% | ||
| Q1 24 | 5.7% | 8.0% |
| Q4 25 | 6.7% | 4.6% | ||
| Q3 25 | 3.4% | 6.2% | ||
| Q2 25 | 3.9% | 7.9% | ||
| Q1 25 | 4.1% | 7.7% | ||
| Q4 24 | 14.7% | -0.3% | ||
| Q3 24 | 3.8% | 6.5% | ||
| Q2 24 | 0.4% | 7.7% | ||
| Q1 24 | 1.9% | 5.4% |
| Q4 25 | $0.81 | $0.15 | ||
| Q3 25 | $0.42 | $0.23 | ||
| Q2 25 | $0.48 | $0.28 | ||
| Q1 25 | $0.49 | $0.23 | ||
| Q4 24 | $1.75 | $0.00 | ||
| Q3 24 | $0.46 | $0.19 | ||
| Q2 24 | $0.05 | $0.25 | ||
| Q1 24 | $0.24 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $353.1M | $5.6M |
| Total DebtLower is stronger | $2.0B | — |
| Stockholders' EquityBook value | $-515.1M | $85.8M |
| Total Assets | $2.8B | $105.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $353.1M | $5.6M | ||
| Q3 25 | $305.5M | $23.0M | ||
| Q2 25 | $320.9M | $21.2M | ||
| Q1 25 | $329.4M | $19.4M | ||
| Q4 24 | $415.3M | $16.7M | ||
| Q3 24 | $402.5M | $20.6M | ||
| Q2 24 | $374.0M | $14.6M | ||
| Q1 24 | $398.3M | $12.0M |
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $2.4B | $2.5M |
| Q4 25 | $-515.1M | $85.8M | ||
| Q3 25 | $-612.0M | $82.8M | ||
| Q2 25 | $-660.5M | $78.7M | ||
| Q1 25 | $-736.0M | $74.2M | ||
| Q4 24 | $-801.1M | $71.9M | ||
| Q3 24 | $-954.2M | $71.5M | ||
| Q2 24 | $-1.0B | $68.0M | ||
| Q1 24 | $-1.0B | $63.5M |
| Q4 25 | $2.8B | $105.6M | ||
| Q3 25 | $2.7B | $109.5M | ||
| Q2 25 | $2.7B | $98.3M | ||
| Q1 25 | $2.7B | $93.7M | ||
| Q4 24 | $2.7B | $90.5M | ||
| Q3 24 | $2.7B | $91.3M | ||
| Q2 24 | $2.6B | $84.9M | ||
| Q1 24 | $2.6B | $82.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $98.3M | $267.0K |
| Free Cash FlowOCF − Capex | $79.8M | $-17.4M |
| FCF MarginFCF / Revenue | 6.2% | -31.5% |
| Capex IntensityCapex / Revenue; lower = less reinvestment burden | 1.4% | 31.9% |
| Cash ConversionOCF / Net Profit; >1× = earnings back up with cash | 1.15× | 0.11× |
| TTM Free Cash FlowTrailing 4 quarters | $252.9M | $-16.4M |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $98.3M | $267.0K | ||
| Q3 25 | $138.8M | $6.9M | ||
| Q2 25 | $96.0M | $3.9M | ||
| Q1 25 | $200.0K | $-150.0K | ||
| Q4 24 | $69.6M | $-2.6M | ||
| Q3 24 | $99.5M | $7.5M | ||
| Q2 24 | $102.5M | $6.5M | ||
| Q1 24 | $13.8M | $1.5M |
| Q4 25 | $79.8M | $-17.4M | ||
| Q3 25 | $118.0M | $1.8M | ||
| Q2 25 | $73.2M | $1.6M | ||
| Q1 25 | $-18.1M | $-2.4M | ||
| Q4 24 | $43.9M | $-3.8M | ||
| Q3 24 | $72.4M | $5.9M | ||
| Q2 24 | $66.2M | $5.1M | ||
| Q1 24 | $-19.1M | $-923.0K |
| Q4 25 | 6.2% | -31.5% | ||
| Q3 25 | 9.3% | 3.1% | ||
| Q2 25 | 5.8% | 3.0% | ||
| Q1 25 | -1.5% | -5.1% | ||
| Q4 24 | 3.6% | -8.2% | ||
| Q3 24 | 5.8% | 12.8% | ||
| Q2 24 | 5.2% | 10.4% | ||
| Q1 24 | -1.5% | -2.1% |
| Q4 25 | 1.4% | 31.9% | ||
| Q3 25 | 1.6% | 9.0% | ||
| Q2 25 | 1.8% | 4.3% | ||
| Q1 25 | 1.5% | 4.8% | ||
| Q4 24 | 2.1% | 2.7% | ||
| Q3 24 | 2.2% | 3.3% | ||
| Q2 24 | 2.8% | 2.9% | ||
| Q1 24 | 2.6% | 5.5% |
| Q4 25 | 1.15× | 0.11× | ||
| Q3 25 | 3.21× | 1.96× | ||
| Q2 25 | 1.95× | 0.92× | ||
| Q1 25 | 0.00× | -0.04× | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | 2.10× | 2.50× | ||
| Q2 24 | 21.81× | 1.73× | ||
| Q1 24 | 0.57× | 0.64× |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
Revenue Breakdown by Segment
HLF
| Others | $514.4M | 40% |
| Other | $300.0M | 23% |
| IN | $250.3M | 20% |
| MX | $147.2M | 11% |
| VN | $71.1M | 6% |
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |